Ballerup, Denmark

Tina Møller Tagmose

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2009-2016

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations of Tina Møller Tagmose

Introduction

Tina Møller Tagmose is a prominent inventor based in Ballerup, Denmark. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments for various metabolic disorders. With a total of 10 patents to her name, her work has had a substantial impact on the medical community.

Latest Patents

One of her latest patents involves Fibroblast Growth Factor 21 (FGF21) derivatives with an albumin binder. This invention relates to compounds that have an albumin binder of the formula A-B-C-D-E- covalently attached. The derivatives are designed to improve the treatment of conditions such as diabetes, dyslipidemia, obesity, cardiovascular diseases, metabolic syndrome, and Non-Alcoholic Fatty Liver Disease (NAFLD). These compounds are capable of maintaining low blood glucose levels for extended periods, increasing the in vivo half-life of FGF21, and improving oxidative stability. Another significant patent involves insulin albumin conjugates, which consist of an insulin analogue, a bifunctional linker, and albumin. These conjugates are effective in treating diabetic patients.

Career Highlights

Tina Møller Tagmose works at Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care and other chronic conditions. Her innovative research and development efforts have positioned her as a key figure in the advancement of therapeutic solutions.

Collaborations

Some of her notable coworkers include Peter Madsen and Thomas Hoeg-Jensen, who have collaborated with her on various projects within the pharmaceutical domain.

Conclusion

Tina Møller Tagmose's contributions to the field of pharmaceuticals through her innovative patents and research have made a significant impact on the treatment of metabolic disorders. Her work continues to inspire advancements in medical science and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…